Literature DB >> 3170454

Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.

M G Aman1, A J White.   

Abstract

Eleven residents receiving long-term thioridazine treatment were studied while receiving their previous dose, standardized low and high doses (1.25 and 2.50 mg/kg per day), and placebo conditions. For theoretical reasons, subjects were also classified by degree of stereotypic behavior on the Fairview Problem Behavior Checklist (Barron & Sandman, 1983). Ratings of hyperactivity and self-injury were significantly lower during the higher as compared with the lower dose condition. Subjects classified as in the high-stereotypy group had significantly and substantially higher levels of maladaptive behavior on several other clinical variables. When all four drug conditions were compared, no significant drug effects were detected. However, high-stereotypy subjects responded significantly better to the drug than low-stereotypy subjects on ratings of Lethargy/Social Withdrawal and Hyperactivity on the Aberrant Behavior Checklist (Aman, Singh, Stewart, & Field, 1985a). The findings were related to previous dosage research and the literature on stereotypic behavior.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170454     DOI: 10.1007/bf02212192

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  15 in total

1.  A method for combining occurrence and nonoccurrence interobserver agreement scores.

Authors:  F C Harris; B B Lahey
Journal:  J Appl Behav Anal       Date:  1978

2.  Psychometric characteristics of the aberrant behavior checklist.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

3.  NIMH review of fraud charge moves slowly.

Authors:  C Holden
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

4.  Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients.

Authors:  J Barron; C A Sandman
Journal:  Am J Ment Defic       Date:  1983-09

5.  An applied dose-response curve of thioridazine with the mentally retarded: aggressive, self-stimulatory, intellectual, and workshop behaviors--a preliminary report.

Authors:  S E Breuning
Journal:  Psychopharmacol Bull       Date:  1982-01

6.  Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design.

Authors:  I L Cohen; M Campbell; D Posner; A M Small; D Triebel; L T Anderson
Journal:  J Am Acad Child Psychiatry       Date:  1980

7.  Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.

Authors:  M G Aman; N N Singh
Journal:  Appl Res Ment Retard       Date:  1982

8.  Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.

Authors:  M G Aman; C J Teehan; A J White; S H Turbott; C Vaithianathan
Journal:  Am J Ment Retard       Date:  1989-01

9.  Short-term effect of thioridazine tablets versus suspension on emotionally disturbed/retarded children.

Authors:  I Jakab
Journal:  J Clin Psychopharmacol       Date:  1984-08       Impact factor: 3.153

10.  A critical appraisal of recent drug research in mental retardation: the Coldwater studies.

Authors:  M G Aman; N N Singh
Journal:  J Ment Defic Res       Date:  1986-09
View more
  3 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

3.  Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.

Authors:  J A Yaryura-Tobias; M S Grunes; M E Bayles; F Neziroglu
Journal:  Eat Weight Disord       Date:  1998-12       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.